| 42 | 0 | 37 |
| 下载次数 | 被引频次 | 阅读次数 |
提出基于系统生物学构建中西医融合恶性肿瘤症状群(CSCs)的研究框架。在本体论层面,论证CSCs与中医证候作为复杂适应系统表型的同一性;在方法论层面,建立系统生物学方法学与中医“病-证-症”体系的映射关系,构建涵盖辨病、辨症、辨证、组学及数字表型的五层数据融合体系;在实践论层面,提出面向因果推断的分子网络解析、数字表型驱动的动态监测及篮式试验设计三大转化路径。本框架可为CSCs的整合研究提供可操作的方法学指南,推动恶性肿瘤支持治疗从碎片化对症干预向系统化调态转型。
Abstract:This article proposes a systems biology-based research framework for the cancer symptom clusters(CSCs) within integrative traditional Chinese and western medicine studies. At the ontological level, it argues for the conceptual correspondence between CSCs and traditional Chinese medicine(TCM) syndromes as phenotypic manifestations of complex adaptive systems. At the methodological level, a mapping relationship is established between systems biology approaches and the TCM framework of "disease-syndrome-symptom", and a five-layer data integration system encompassing disease differentiation, symptom differentiation, syndrome differentiation, omics data, and digital phenotypes is constructed. At the practical level, three major translational pathways are proposed, including molecular network analysis for causal inference, digital phenotype-driven dynamic monitoring, and basket trial design. This framework may provide an operational methodological guide for the integrative study on CSCs and facilitate the transformation of supportive cancer care from fragmented symptom-oriented interventions toward systematic regulation of the overall functional state.
[1]PDQ Supportive and Palliative Care Editorial Board.Symptom clusters in cancer(PDQ®):health professional version[R/OL]//National Cancer Institute.PDQ Cancer Information Summaries.Bethesda:National Cancer Institute,2024.https://www.cigna.com/knowledge-center/hw/medical-topics/symptom-clusters-in-cancer-ncicdr0000814132.
[2]Miaskowski C,Barsevick A,Berger A,et al.Advancing symptom science through symptom cluster research:expert panel proceedings and recommendations[J/OL].J Natl Cancer Inst,2017,109(4):djw253.https://pubmed.ncbi.nlm.nih.gov/28119347/.
[3]Kim H J,Mc Guire D B,Tulman L,et al.Symptom clusters:concept analysis and clinical implications for cancer nursing[J].Cancer Nurs,2005,28(4):270-282.
[4]Mingqian H,Yue J,Juan F,et al.A scoping review of symptom clusters during chemotherapy in colorectal cancer patients[J/OL].Support Care Cancer,2026,34(4):300.https://pubmed.ncbi.nlm.nih.gov/41807672/.
[5]Li X,Zou Y,Zhang Z,et al.Chemotherapy-related symptom networks in distinct subgroups of Chinese patients with gastric cancer[J/OL].Asia-Pacific J Oncol Nurs,2024,11(3):100366.https://pubmed.ncbi.nlm.nih.gov/38362311/.
[6]Fu L,Feng X,Jin Y,et al.Symptom clusters and quality of life in gastric cancer patients receiving chemotherapy[J].J Pain Symptom Manage,2022,63(2):230-243.
[7]Qi Y,Li H,Guo Y,et al.Symptom clusters in breast cancer patients receiving adjuvant chemotherapy:a systematic review[J].J Clin Nurs,2024,33(12):4554-4567.
[8]Ideker T,Galitski T,Hood L.A new approach to decoding life:systems biology[J/OL].Annu Rev Genomics Hum Genet,2001,2:343-372.https://pubmed.ncbi.nlm.nih.gov/11701654/.
[9]Barabási A L,Oltvai Z N.Network biology:understanding the cell's functional organization[J].Nat Rev Genet,2004,5(2):101-113.
[10]黄丁平,李文娟.中医疏肝健脾法治疗肝癌的研究进展[J].癌症进展,2025,23(1):22-24.
[11]仝小林,何莉莎,赵林华.论“态靶因果”中医临床辨治方略[J].中医杂志,2015,56(17):1441-1444.
[12]Hood L.Systems biology:integrating technology,biology,and computation[J].Mech Ageing Dev,2003,124(1):9-16.
[13]Luo T T,Lu Y,Yan S K,et al.Network pharmacology in research of Chinese medicine formula:methodology,application and prospective[J].Chin J Integr Med,2020,26(1):72-80.
[14]Harris C S,Miaskowski C A,Conley Y P,et al.Epigenetic regulation of inflammatory mechanisms and a psychological symptom cluster in patients receiving chemotherapy[J].Nurs Res,2023,72(3):200-210.
[15]Mantovani A,Dinarello C A,Molgora M,et al.Interleukin-1 and related cytokines in the regulation of inflammation and immunity[J].Immunity,2019,50(4):778-795.
[16]Gabay C,Kushner I.Acute-phase proteins and other systemic responses to inflammation[J].N Engl J Med,1999,340(6):448-454.
[17]Johnson C H,Ivanisevic J,Siuzdak G.Metabolomics:beyond biomarkers and towards mechanisms[J].Nat Rev Mol Cell Biol,2016,17(7):451-459.
[18]Gilbert J A,Blaser M J,Caporaso J G,et al.Current understanding of the human microbiome[J].Nat Med,2018,24(4):392-400.
[19]Langfelder P,Horvath S.WGCNA:an R package for weighted correlation network analysis[J/OL].BMC Bioinformatics,2008,9:559.https://pubmed.ncbi.nlm.nih.gov/19114008/.
[20]Davey Smith G,Hemani G.Mendelian randomization:genetic anchors for causal inference in epidemiological studies[J/OL].Hum Mol Genet,2014,23(R1):R89-R98.https://pubmed.ncbi.nlm.nih.gov/25064373/.
[21]Argelaguet R,Cuomo A S E,Stegle O,et al.Computa-tional principles and challenges in singlecell data integration[J].Nat Biotechnol,2021,39(10):1202-1215.
[22]Kitano H.Computational systems biology[J].Nature,2002,420(6912):206-210.
[23]Redig A J,Jänne P A.Basket trials and the evolution of clinical trial design in an era of genomic medicine[J].J Clin Oncol,2015,33(9):975-977.
基本信息:
DOI:10.13288/j.11-2166/r.2026.22.006
中图分类号:R730.5
引用信息:
[1]吴俊汎,杨雯靖,王雪玉,等.基于系统生物学构建中西医融合恶性肿瘤症状群研究框架[J].中医杂志,2026,67(22):2397-2402.DOI:10.13288/j.11-2166/r.2026.22.006.
基金信息:
国家科技重大专项(2024ZD0521401)
2026-11-17
2026-11-17